Gibson Dunn Reps Accuray In $277M Radiotherapy Deal
Accuray, based in Sunnyvale, said it will acquire TomoTherapy Inc. for $4.80 per share in cash and stock. Accuray president and CEO Euan S. Thomson said the acquisition will create a company that will provide patients with treatments ranging from high-precision radiosurgery to image-guided, intensity-modulated radiation therapy.
“The combined company will also...
To view the full article, register now.